Earnings Per Share Information (Tables)

9 Months Ended

Jul. 31, 2023

The table below provides, for the periods indicated, information pertaining to the calculation of earnings per share, common stock equivalents, weighted-average number of antidilutive options, and shares issued (amounts in thousands):


	Three months ended July 31,				Nine months ended July 31,
	2023		2022		2023		2022
Numerator:
Net income as reported	$	414,789	$	273,467	$	926,535	$	645,964

Denominator:
Basic weighted-average shares	110,003		115,334		110,871		118,056
Common stock equivalents (1)	1,120		992		1,010		1,313
Diluted weighted-average shares	111,123		116,326		111,881		119,369

Other information:

Weighted-average number of antidilutive options and restricted stock units (2)	121		407		395		275
Shares issued under stock incentive and employee stock purchase plans	548		45		1,984		469

(1) Common stock equivalents represent the dilutive effect of outstanding in-the-money stock options using the treasury stock method and shares expected to be issued upon the conversion of restricted stock units under our equity award programs.

(2) Weighted-average number of antidilutive options and restricted stock units are based upon the average closing price of our common stock on the New York Stock Exchange for the period.